Egypt Glucose Monitoring Devices Market, By Product (Self-Monitoring Glucose Devices, Continuous Glucose Monitoring Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital, Others), By Region, Competition, Forecast & Opportunities, 2019-2029F

Market Overview

The Egyptian glucose monitoring devices market was valued at USD 370.6 Million in 2023 and is expected to reach USD 534.78 Million by 2029, with a CAGR of 6.25% during the forecast period. The Egypt glucose monitoring devices market is experiencing significant growth driven by increasing awareness of diabetes management and rising healthcare expenditures. Glucose monitoring devices play a crucial role in the daily management of diabetes by providing accurate, timely blood sugar readings, empowering patients to make informed decisions about their health.

Key factors contributing to the market's growth include a growing diabetic population, lifestyle changes leading to higher incidence of diabetes, and advancements in technology making monitoring devices more accurate and user-friendly. In Egypt, the prevalence of diabetes has been on the rise, fueled by factors such as urbanization, sedentary lifestyles, and dietary changes. This trend has created a pressing need for effective glucose monitoring solutions to help individuals better manage their condition.

For instance, In January 2024, GlucoTrack is preparing to initiate first-in-human studies for its implantable continuous glucose monitor (CBGM) following the successful completion of preclinical trials. The US-based company, headquartered in New Jersey, has completed initial studies on device safety and implantation techniques, modeled after established cardiovascular implant procedures. The preclinical assessments have paved the way for upcoming human trials, marking a significant step forward in advancing glucose monitoring technology. Trial initiation is anticipated later this year, underscoring GlucoTrack's commitment to developing innovative solutions to improve diabetes management through continuous glucose monitoring.

The market for glucose monitoring devices in Egypt includes continuous glucose monitoring systems (CGMS), self-monitoring of blood glucose (SMBG) systems, and other devices. SMBG systems, which allow patients to measure their blood glucose levels at home, dominate the market due to their affordability and ease of use. Government initiatives to improve healthcare infrastructure and expand access to diabetes management tools are also contributing to market growth. Therefore, partnerships among healthcare providers, technology companies, and diabetes organizations are fostering innovation and driving the adoption of advanced monitoring devices nationwide.

Key Market Drivers

Rising Diabetes Prevalence

The rising prevalence of diabetes in Egypt is a significant driver impacting the glucose monitoring devices market. Over recent years, Egypt has seen a steady increase in diabetes cases, primarily attributed to changes in lifestyle, urbanization, and dietary habits. Urban areas, where lifestyle factors such as sedentary behavior and high-calorie diets are prevalent, report higher incidences of diabetes compared to rural regions. According to the International Diabetes Federation (IDF), Egypt has one of the highest prevalence rates of diabetes in the Middle East and North Africa region.

The IDF estimated that in 2019, approximately 8.5 million adults aged 20-79 years were living with diabetes in Egypt. This number is expected to rise further due to population growth, aging, and ongoing urbanization. The impact of diabetes extends beyond health concerns to economic implications, as the disease places a significant burden on healthcare systems and individuals alike. For instance, according to the IDF, Egypt ranks ninth globally in diabetes prevalence, with approximately 8,850,400 adult diabetic patients as of early 2020, reflecting a prevalence rate of 15.2%. Egypt is part of the Middle East and North Africa (MENA) region within the IDF. The IDF projects that the number of diabetic patients in the MENA region will double by 2045, reaching 108 million. Alarmingly, 40% to 50% of individuals with diabetes or prediabetes remain undiagnosed, underscoring significant under-recognition of the disease. Egypt is expected to see a substantial increase in diabetic patients by 2035, highlighting the urgent need for enhanced diabetes awareness, screening, and management strategies in the country.

Effective diabetes management, including regular monitoring of blood glucose levels, is crucial in preventing complications such as cardiovascular diseases, kidney problems, and diabetic retinopathy. In response to the growing diabetes burden, there is an increasing demand for glucose monitoring devices in Egypt. These devices enable individuals with diabetes to monitor their blood sugar levels conveniently at home or on the go, empowering them to make timely adjustments to their treatment plans. Continuous innovations in glucose monitoring technology, including more accurate sensors and user-friendly devices, are further driving market growth by enhancing the effectiveness and ease of diabetes management.

The rising prevalence of diabetes in Egypt underscores the critical need for accessible and effective diabetes management solutions, positioning the glucose monitoring devices market for continued expansion and innovation.

Growing Awareness and Education

Growing awareness and education about diabetes management are playing a crucial role in shaping Egypt’s glucose monitoring devices market, as more healthcare professionals and patients recognize that regular blood glucose monitoring is central to effective diabetes control and complication prevention. For instance, Egypt’s Ministry of Health and Population announced that 12.3 million Egyptians have been examined since the launch of the Early Detection and Treatment of Chronic Diseases and Nephropathy presidential initiative, which was launched in September 2021 with 3,601 primary care units nationwide and includes blood pressure and diabetes tests alongside awareness services about chronic disease risk factors, directly expanding screening, counseling, and the practical need for routine glucose monitoring.

These efforts aim to empower people living with diabetes to take proactive steps to manage their condition and prevent complications, and patients are increasingly informed about the range of glucose monitoring options such as self monitoring of blood glucose systems and continuous glucose monitoring systems and how to integrate testing into daily routines. Healthcare professionals are also becoming more adept at recommending appropriate monitoring approaches based on patient needs, which can improve adherence and outcomes through more personalized diabetes care. For instance, the Egypt Healthcare Authority launched a World Diabetes Day awareness campaign across its facilities in Port Said, Luxor, Ismailia, South Sinai, Suez, and Aswan that included random blood sugar screenings and HbA1c tests and reached 10,000 citizens including 1,000 children, illustrating how combined education plus onsite testing can translate into higher acceptance and use of glucose monitoring tools.

In Egypt, this growing awareness and education is supported by collaborations among healthcare providers, government bodies, and partners working through national initiatives and facility-based campaigns that disseminate accurate information, promote early diagnosis, and normalize ongoing monitoring as part of diabetes management. As awareness increases and more people are screened, diagnosed, and followed up through primary care units and universal health insurance governorates, demand rises for reliable glucose monitoring devices that support day-to-day decisions and help reduce avoidable complications.

Download Free Sample Report

Key Market Challenges

Economic Constraints

Economic constraints pose significant challenges to the Egypt glucose monitoring devices market, affecting both supply and demand dynamics crucial for the adoption and accessibility of these critical medical tools. Affordability remains a primary issue, particularly for advanced technologies such as continuous glucose monitoring systems (CGMS), which can be prohibitively expensive for many individuals, especially those without adequate health insurance coverage. The overall healthcare expenditure in Egypt, while increasing, may not always align with the growing demand for sophisticated medical devices, limiting their availability in public healthcare facilities and affordability for patients.

Currency fluctuations further exacerbate the unpredictability of pricing for imported devices, affecting budgeting and purchasing decisions. Insurance coverage for glucose monitoring devices varies widely, with gaps in comprehensive coverage that can place financial burdens on patients who require regular monitoring. These economic challenges not only affect market growth but also hinder investment in research and development of new technologies tailored to the local market's needs. Addressing these constraints requires collaboration among healthcare providers, policymakers, insurers, and manufacturers to develop strategies that enhance affordability, expand insurance coverage, and ensure sustainable access to glucose monitoring devices for all individuals with diabetes in Egypt.

Healthcare Infrastructure

Healthcare infrastructure plays a pivotal role in shaping the Egypt glucose monitoring devices market, influencing both the distribution and utilization of these essential medical technologies. Egypt's healthcare system faces challenges related to disparities between urban and rural areas, where access to healthcare facilities and specialized services can vary significantly. Urban centers generally have better-equipped hospitals and clinics that offer advanced diabetes management, including access to a variety of glucose monitoring devices.

In contrast, rural areas may lack sufficient infrastructure and resources, limiting residents' access to and use of these devices. The uneven distribution of healthcare infrastructure impacts the adoption rates of glucose monitoring technologies across the country. Patients in remote or underserved regions may face barriers such as long travel distances to healthcare facilities, limited availability of trained healthcare professionals, and inadequate medical device supply chains. These challenges contribute to disparities in diabetes care outcomes and hinder efforts to effectively manage and monitor the disease nationwide.

Efforts to improve healthcare infrastructure are crucial to advancing Egypt's glucose monitoring devices market. This includes investment in upgrading and expanding healthcare facilities, enhancing medical equipment procurement and maintenance systems, and strengthening healthcare delivery networks. Addressing these infrastructure gaps can help ensure equitable access to glucose monitoring devices, improve diabetes management outcomes, and reduce the overall burden of the disease on individuals and the healthcare system alike.

Key Market Trends

Shift towards Continuous Glucose Monitoring (CGM) Systems

In Egypt, there is a notable shift toward the adoption of continuous glucose monitoring systems, reflecting global trends toward more advanced diabetes management solutions. CGM systems offer significant advantages over traditional self-monitoring blood glucose systems by providing continuous real-time data on glucose levels throughout the day and night. This continuous monitoring helps patients and clinicians better understand glucose fluctuations, which is particularly beneficial for people requiring intensive management, such as those using insulin or experiencing unstable blood sugar levels.

The adoption of CGM systems in Egypt is driven by increasing awareness among healthcare providers and patients about the clinical value of continuous monitoring in improving glycemic control and reducing the risk of diabetes-related complications. For instance, Egypt’s Ministry of Health and Population reported that 12.3 million Egyptians have been examined under the Early Detection and Treatment of Chronic Diseases and Nephropathy presidential initiative, launched in September 2021 through 3,601 primary care units nationwide, and the initiative includes blood pressure and diabetes tests as well as awareness services on chronic disease risk factors, which helps normalize routine monitoring and strengthens readiness for technology-enabled options like CGM.

Advancements in CGM technology have also led to devices that are more accurate, user-friendly, and less invasive than earlier models, with sensors that require minimal calibration, longer wear times, and wireless data transmission to smartphones or other devices for real-time monitoring and analysis. These improvements reduce the day-to-day burden of diabetes management and can support more timely dose and lifestyle adjustments.

As healthcare infrastructure in Egypt continues to improve and access to healthcare services expands, there is growing demand for advanced medical technologies like CGM systems. For instance, the Egypt Healthcare Authority launched a World Diabetes Day awareness campaign across its facilities in six Universal Health Insurance governorates and reported that it benefited 10,000 citizens, including 1,000 children, while delivering random blood sugar screenings and HbA1c tests alongside education on prevention, early diagnosis, and regular glucose monitoring.

This trend is supported by collaborations among healthcare providers, technology companies, and diabetes organizations to enhance availability and affordability of CGM systems nationwide. Therefore, the shift toward CGM systems in Egypt underscores a move toward more personalized and effective diabetes management strategies, positioning these technologies as increasingly important components of modern diabetes care in the country.

Integration with Digital Health Platforms

Integration with digital health platforms is becoming increasingly relevant in the Egypt glucose monitoring devices market, revolutionizing how diabetes management is approached and enhancing patient outcomes. Digital health platforms include smartphone apps, web portals, and cloud-based systems that connect glucose monitoring devices to digital interfaces, enabling seamless data collection, analysis, and communication between patients and healthcare providers. In Egypt, integrating glucose monitoring devices with digital health platforms offers several key advantages. It enables patients to easily track their glucose levels over time, review trends, and gain insights into their diabetes management.

This access to real-time data empowers patients to make informed decisions about diet, exercise, medication, and insulin dosing, leading to better glycemic control and reduced risk of complications. Digital platforms facilitate remote monitoring and telehealth consultations, which are particularly valuable in a country where access to specialized healthcare services may be limited in certain regions. Patients can securely share their glucose data with healthcare providers, who can then provide timely feedback, treatment plan adjustments, and personalized recommendations without frequent in-person visits.

The integration with digital health platforms promotes patient engagement and adherence to monitoring regimens by offering features such as reminders for testing, medication adherence tracking, and educational resources. These platforms also support caregivers and family members in monitoring the health status of loved ones with diabetes, fostering a collaborative approach to disease management. Therefore, the integration of glucose monitoring devices with digital health platforms in Egypt is transforming diabetes care by improving accessibility, efficiency, and effectiveness of monitoring and management strategies. As these technologies continue to evolve, they hold promise for further enhancing healthcare outcomes and quality of life for individuals living with diabetes in the country.

Segmental Insights

Product Insights

Based on the Product, self-monitoring blood glucose (SMBG) devices dominated the market over continuous glucose monitoring (CGM) devices, particularly in Egypt. The main reason for this dominance is affordability and accessibility. SMBG devices are generally more affordable for patients and healthcare systems, making them widely accessible across different socioeconomic groups. They are also easier to use and require less frequent calibration compared to CGM systems, which can be advantageous in settings where resources and infrastructure for continuous monitoring may be limited.

SMBG devices are well-established in clinical practice and are often covered by health insurance policies, further supporting their widespread use. However, the trend is gradually shifting towards CGM systems as technology advances, costs decrease, and awareness of their benefits grows. CGM systems offer continuous, real-time monitoring, providing more comprehensive data for managing diabetes effectively, thereby appealing to patients and healthcare providers seeking tighter glucose control and improved outcomes.

Application Insights

Based on the application, Type 2 diabetes was dominated globally and, in many regions, including Egypt. This dominance is primarily due to its higher prevalence compared to Type 1 diabetes and gestational diabetes. Type 2 diabetes is characterized by insulin resistance and relative insulin deficiency, often associated with lifestyle factors such as obesity, physical inactivity, and unhealthy diet patterns. In Egypt, rapid urbanization, changing dietary habits, and sedentary lifestyles have contributed to the rising prevalence of Type 2 diabetes.

Type 2 diabetes is more commonly diagnosed in adults, whereas Type 1 diabetes typically manifests in childhood or adolescence and accounts for a smaller proportion of diabetes cases. Gestational diabetes, which develops during pregnancy, also affects a smaller percentage of women temporarily. Due to its prevalence and associated risk factors, Type 2 diabetes represents a significant public health challenge in Egypt and globally, requiring comprehensive strategies for prevention, early detection, and management to mitigate its impact on individuals and healthcare systems.

Download Free Sample Report

Regional Insights

Cairo, as Egypt's capital and largest city, holds a dominant position in the country's glucose monitoring devices market for several key reasons. It has a dense population and better healthcare infrastructure and accessibility than other regions. Cairo is home to leading hospitals, clinics, and healthcare providers equipped to offer advanced diabetes care and a wide range of monitoring devices. The city's concentration of healthcare professionals, research institutions, and market demand contributes significantly to the adoption and distribution of glucose monitoring technologies, making it a central hub for diabetes management innovations in Egypt.

Recent Developments

• In June 2025, Roche Diagnostics Egypt and UPA signed an MoU focused on embedding sustainability/“green procurement” principles and capacity building within healthcare procurement and supply practices.
• In December 2024, Abbott’s FreeStyle Libre Egypt website presented the FreeStyle Libre 2 System product information for Egypt, describing continuous sensor-based glucose readings to a smartphone with optional alarms.
• In June 2024, in Cairo, Egypt, Roche announced the signing of two strategic partnerships aimed at enhancing diabetes care for Egyptian children under 18 over the next five years. These collaborations align with Egypt's 2030 vision to achieve universal healthcare access for all citizens. The first Memorandum of Understanding (MoU) involves Roche Diagnostics, the Egypt Healthcare Authority (EHA), and the Egyptian Authority for Unified Procurement, Medical Supply, and Technology Management (UPA). The second agreement is between Roche Diagnostics and the General Authority for Health Insurance (GHA) under the Ministry of Health and Population, in conjunction with the UPA. These partnerships underscore Roche's commitment to leveraging its expertise and resources in conjunction with Egyptian healthcare authorities to improve diabetes management and ensure equitable access to healthcare services across the country.

Key Market Players

• Abbott Egypt
• Agilent Egypt
• Roche Egypt LLC
• FUJIFILM Healthcare Middle East S.A.E.
• Siemens Healthineers Egypt
• Johnson & Johnson
• GE Healthcare Egypt
• Ortho Clinical Diagnostics
• PerkinElmer International C.V.
• LifeScan Egypt

Report Scope:

In this report, the Egypt Glucose Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·         Egypt Glucose Monitoring Devices Market, By Product:

o   Self-Monitoring Glucose Devices

o   Continuous Glucose Monitoring Devices

·         Egypt Glucose Monitoring Devices Market, By Application:

o   Type 1 Diabetes

o   Type 2 Diabetes

o   Gestational Diabetes  

·         Egypt Glucose Monitoring Devices Market, By End User:

o   Home Care Settings

o   Hospital

o   Others

•            Egypt Glucose Monitoring Devices Market, By Region:

o   Cairo

o   Alexandria

o   Giza

o   Qalyubia

o   Port Said

o   Suez

o   Rest of Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Egypt Glucose Monitoring Devices Market.

Available Customizations:

Egypt Glucose Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Egypt Glucose Monitoring Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]